Ujjwal Kumar De
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ujjwal Kumar De has a total of 114 co-authors. Here are the top co-authors by number of shared publications:
Varun Kumar Sarkar
Division of Medicine, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh 243 122, India
7 shared publicationsReena Mukherjee
Indian Vet Res Inst, Div Med, Izatnagar, Uttar Pradesh, India
5 shared publicationsAnju Kala
Division of Animal Nutrition, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh 243 122, India
4 shared publicationsBabul Rudra Paul
Division of Medicine, ICAR-Indian Veterinary Research Institute, Izatnagar-243122, Uttar Pradesh, India
4 shared publicationsJitendra Singh Gandhar
Division of Medicine, ICAR-Indian Veterinary Research Institute, Izatnagar, 243 122, Bareilly, Uttar Pradesh, India
4 shared publicationsManas Kumar Patra
Livestock Production and Management Section, ICAR-Indian Veterinary Research Institute, Izatnagar, 243 122, Bareilly, Uttar Pradesh, India
4 shared publications
Latest Publications
- 2 August 2025
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17  (5) , 2856-2877
Exploring the Therapeutic Landscape of Probiotics in Enteric and Respiratory Viral Infections
In recent times, the understanding of the human microbiome and its impact on health and disease has undergone a paradigm shift, leading to ground-breaking discoveries in the field of probiotics. Probiotics, live microorganisms known for conferring health benefits when administered adequately, have garnered significant interest for their potential to modulate the immune system’s response to viral infections in both humans and animals. The emergence of enteric and respiratory viruses as significant global health threats has prompted intensive research efforts to identify novel therapeutic strategies. Traditional antiviral therapies often face challenges such as drug resistance, limited efficacy and adverse effects, underscoring the urgent need for alternative approaches. In this context, probiotics have emerged as a promising avenue for the prevention and treatment of viral infections due to their ability to modulate the host immune response, enhance mucosal barrier function and exert direct antiviral effects. This review aims to provide a comprehensive overview of the therapeutic landscape of probiotics against enteric and respiratory viruses. Based on latest findings from preclinical and clinical studies, we have explored the mechanisms underlying the antiviral activity of probiotics and their potential role in mitigating viral infections. Furthermore, promising avenues for harnessing probiotics as adjunctive or standalone interventions against enteric and respiratory viral infections have been discussed here.
- 2 August 2025
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17  (5) , 2856-2877
Exploring the Therapeutic Landscape of Probiotics in Enteric and Respiratory Viral Infections
In recent times, the understanding of the human microbiome and its impact on health and disease has undergone a paradigm shift, leading to ground-breaking discoveries in the field of probiotics. Probiotics, live microorganisms known for conferring health benefits when administered adequately, have garnered significant interest for their potential to modulate the immune system’s response to viral infections in both humans and animals. The emergence of enteric and respiratory viruses as significant global health threats has prompted intensive research efforts to identify novel therapeutic strategies. Traditional antiviral therapies often face challenges such as drug resistance, limited efficacy and adverse effects, underscoring the urgent need for alternative approaches. In this context, probiotics have emerged as a promising avenue for the prevention and treatment of viral infections due to their ability to modulate the host immune response, enhance mucosal barrier function and exert direct antiviral effects. This review aims to provide a comprehensive overview of the therapeutic landscape of probiotics against enteric and respiratory viruses. Based on latest findings from preclinical and clinical studies, we have explored the mechanisms underlying the antiviral activity of probiotics and their potential role in mitigating viral infections. Furthermore, promising avenues for harnessing probiotics as adjunctive or standalone interventions against enteric and respiratory viral infections have been discussed here.
- Open Access
- 16 June 2025
- Published by IK Press in UTTAR PRADESH JOURNAL OF ZOOLOGY
- Vol. 46  (12) , 303-310
Effects of Multi-Strain Probiotics and Early Life Multi-Mineralization on Iron-Zinc Homeostasis in Neonatal Piglets
The present study was conducted to investigate the effect of multi-strain probiotics and multi-minerals on iron-zinc homeostasis in neonatal piglets. Eight apparently healthy sows were selected and randomly divided into four equal groups. Piglets from two sows of each group were taken for study [Control (total piglets-17), multi-minerals (total piglets-22), multi-strain probiotics (total piglets-15) and multi-minerals + multi-strain probiotics (total piglets-23)]. The Blood samples were collected from anterior vena cava of piglets on day 0, 7, 14 and 21 post-farrowing. The zinc and iron concentration were measured using spectrophotometer. The results revealed that the mean zinc and iron concentrations were markedly higher in multi-minerals group as compare to control, multi-strain probiotics and multi-minerals + multi-strain probiotics groups on day 0. Moreover, that in MM group, Zn concentration on day 14 and 21 and iron values on day 21 were significantly lower as compared to day 0. The mean concentration of iron on day 7 and zinc on day 7 and 21 were significantly higher as compared to day 0 in multi-strain probiotics group. In multi-minerals + multi-strain probiotics group, mean concentration of iron on day 14 and 21 and zinc value on day 14 were significantly lower as compared to day 0 and day 7. It is concluded that the supplementation of multi-strain probiotics has better effect on iron zinc homeostasis as compare to multi-minerals and multi-minerals + multi-strain probiotics supplementations.
- 16 June 2025
- Published by IK Press in UTTAR PRADESH JOURNAL OF ZOOLOGY
- Vol. 46  (12) , 303-310
Open AccessEffects of Multi-Strain Probiotics and Early Life Multi-Mineralization on Iron-Zinc Homeostasis in Neonatal Piglets
The present study was conducted to investigate the effect of multi-strain probiotics and multi-minerals on iron-zinc homeostasis in neonatal piglets. Eight apparently healthy sows were selected and randomly divided into four equal groups. Piglets from two sows of each group were taken for study [Control (total piglets-17), multi-minerals (total piglets-22), multi-strain probiotics (total piglets-15) and multi-minerals + multi-strain probiotics (total piglets-23)]. The Blood samples were collected from anterior vena cava of piglets on day 0, 7, 14 and 21 post-farrowing. The zinc and iron concentration were measured using spectrophotometer. The results revealed that the mean zinc and iron concentrations were markedly higher in multi-minerals group as compare to control, multi-strain probiotics and multi-minerals + multi-strain probiotics groups on day 0. Moreover, that in MM group, Zn concentration on day 14 and 21 and iron values on day 21 were significantly lower as compared to day 0. The mean concentration of iron on day 7 and zinc on day 7 and 21 were significantly higher as compared to day 0 in multi-strain probiotics group. In multi-minerals + multi-strain probiotics group, mean concentration of iron on day 14 and 21 and zinc value on day 14 were significantly lower as compared to day 0 and day 7. It is concluded that the supplementation of multi-strain probiotics has better effect on iron zinc homeostasis as compare to multi-minerals and multi-minerals + multi-strain probiotics supplementations.
- 28 December 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 199, 107260
Diflunisal attenuates acute inflammatory responses through inhibition of NF-κB signaling pathway in Staphylococcus aureus-induced mastitis of lactating mouse model
- 28 December 2024
- Published by Elsevier in Microbial Pathogenesis
- Vol. 199, 107260
Diflunisal attenuates acute inflammatory responses through inhibition of NF-κB signaling pathway in Staphylococcus aureus-induced mastitis of lactating mouse model
- Open Access
- 12 July 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18  (3) , 1546-1557
Therapeutic Efficacy of Baicalein Green Biomolecule in Methicillin-Resistant Staphylococcus aureus Murine Mastitis Model
Methicillin-resistant Staphylococcus aureus (MRSA) mastitis poses a significant threat to dairy herds worldwide, given its resistance to methicillin and other β-lactam antibiotics, which often leads to treatment failure. Consequently, there is an urgent need for safe and effective alternative therapeutic approaches. Recent investigations have highlighted the potential of baicalein, a natural flavonoid known for its potent anti-inflammatory and antibacterial properties, especially its synergistic effects with β-lactam antibiotics against MRSA. However, the limited solubility and bioavailability of baicalein hinder its biomedical utility. The present study assessed the therapeutic efficacy of encapsulated baicalein in chitosan, forming a tricomplex with a β-lactam antibiotic, using a murine model of MRSA-induced mastitis. The experimental design comprised seven groups, each consisting of six mice. We evaluated the ability of various treatment regimens to mitigate histopathological alterations and bacterial burden induced by MRSA infection, aiming to elucidate underlying mechanisms. Our results revealed that tricomplex treatment significantly reduced bacterial load in mammary tissue and preserved tissue integrity, resulting in decreased inflammatory responses post-MRSA inoculation. In addition, tricomplex treatment markedly reduced mean leukocyte and neutrophil counts in blood and suppressed the matrix metalloproteinase-9 (MMP-9) concentration and C-reactive protein (CRP) response. Notably, the synergistic interaction between baicalein and amoxicillin was particularly pronounced. Our findings suggest that chitosan-encapsulated baicalein combined with a β-lactam antibiotic holds promise as a therapeutic option for MRSA-induced mastitis. Further investigations, particularly in target animal species, are warranted to comprehensively evaluate its clinical feasibility.
- 12 July 2024
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 18  (3) , 1546-1557
Open AccessTherapeutic Efficacy of Baicalein Green Biomolecule in Methicillin-Resistant Staphylococcus aureus Murine Mastitis Model
Methicillin-resistant Staphylococcus aureus (MRSA) mastitis poses a significant threat to dairy herds worldwide, given its resistance to methicillin and other β-lactam antibiotics, which often leads to treatment failure. Consequently, there is an urgent need for safe and effective alternative therapeutic approaches. Recent investigations have highlighted the potential of baicalein, a natural flavonoid known for its potent anti-inflammatory and antibacterial properties, especially its synergistic effects with β-lactam antibiotics against MRSA. However, the limited solubility and bioavailability of baicalein hinder its biomedical utility. The present study assessed the therapeutic efficacy of encapsulated baicalein in chitosan, forming a tricomplex with a β-lactam antibiotic, using a murine model of MRSA-induced mastitis. The experimental design comprised seven groups, each consisting of six mice. We evaluated the ability of various treatment regimens to mitigate histopathological alterations and bacterial burden induced by MRSA infection, aiming to elucidate underlying mechanisms. Our results revealed that tricomplex treatment significantly reduced bacterial load in mammary tissue and preserved tissue integrity, resulting in decreased inflammatory responses post-MRSA inoculation. In addition, tricomplex treatment markedly reduced mean leukocyte and neutrophil counts in blood and suppressed the matrix metalloproteinase-9 (MMP-9) concentration and C-reactive protein (CRP) response. Notably, the synergistic interaction between baicalein and amoxicillin was particularly pronounced. Our findings suggest that chitosan-encapsulated baicalein combined with a β-lactam antibiotic holds promise as a therapeutic option for MRSA-induced mastitis. Further investigations, particularly in target animal species, are warranted to comprehensively evaluate its clinical feasibility.
- 3 May 2024
- Published by Springer Nature
- p. 345-381
Insights on Various Antiviral Drugs for Treating Patients with COVID-19
- 3 May 2024
- Published by Springer Nature
- p. 345-381
Insights on Various Antiviral Drugs for Treating Patients with COVID-19
- Open Access
- 7 June 2023
- Published by Elsevier in Veterinary and Animal Science
- Vol. 21, 100300
Antioxidant supplementation during treatment of outpatient dogs with parvovirus enteritis ameliorates oxidative stress and attenuates intestinal injury: A randomized controlled trial
- 7 June 2023
- Published by Elsevier in Veterinary and Animal Science
- Vol. 21, 100300
Open AccessAntioxidant supplementation during treatment of outpatient dogs with parvovirus enteritis ameliorates oxidative stress and attenuates intestinal injury: A randomized controlled trial